
340B Program Reform Proposals 2026: Key Impacts on Physician-Hospital Partnerships
Congressional scrutiny of the 340B Drug Pricing Program continues into 2026, with new proposals aiming

Congressional scrutiny of the 340B Drug Pricing Program continues into 2026, with new proposals aiming

On February 26, 2026, enforcement activity tied to the federal No Surprises Act continues evolving,

On February 24, 2026, the American Medical Association advanced its federal and state policy strategy

On February 19, 2026, the American College of Physicians (ACP) intensified its push for federal

As of February 17, 2026, the American Academy of Family Physicians (AAFP) continues to elevate

On January 21, 2026, the Medical Group Management Association (MGMA) sent an influential letter to